Shopping Cart
- Remove All
- Your shopping cart is currently empty
Soraprazan (BYK61359) is a selective potassium channel inhibitor that inhibits gastric acid secretion and ameliorates age-related eye disease by removing lipofuscin from retinal pigment epithelial (RPE) cells.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | $447 | In Stock | |
25 mg | $1,530 | In Stock | |
50 mg | $1,990 | In Stock | |
100 mg | $3,280 | In Stock | |
1 mL x 10 mM (in DMSO) | $430 | In Stock |
Description | Soraprazan (BYK61359) is a selective potassium channel inhibitor that inhibits gastric acid secretion and ameliorates age-related eye disease by removing lipofuscin from retinal pigment epithelial (RPE) cells. |
Targets&IC50 | [14C]AP:0.19 μM, 1 mM potassium ions in ion-loss vesicles:0.1 μM |
In vitro | Soraprazan is a potent inhibitor of gastric H,K-ATPase, with an IC50 value of 0.1 μM in the presence of 1 mM potassium ions in ion-loss vesicles, and inhibits dibutyryl cyclic AMP-stimulated [14C]AP accumulation in isolated gastric glands with an IC50 value of 0.19 μM. [1] |
In vivo | Soraprazan 1-27 μmol/kg administered orally showed rapid and stable inhibition of acid secretion in dogs.[1] |
Alias | BYK61359, BYK 61359 |
Molecular Weight | 367.44 |
Formula | C21H25N3O3 |
Cas No. | 261944-46-1 |
Smiles | O(CCOC)[C@@H]1C2=C(C=3N(C=C2)C(C)=C(C)N3)N[C@@H]([C@H]1O)C4=CC=CC=C4 |
Relative Density. | 1.29 g/cm3 (Predicted) |
Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 80 mg/mL (217.72 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.